ProcalAmine |
HUMAN PRESCRIPTION DRUG LABEL |
22 |
0264-1915 |
INJECTION |
0.21 g |
INTRAVENOUS |
NDA |
24 sections
|
TrophAmine |
HUMAN PRESCRIPTION DRUG LABEL |
20 |
0264-1933 |
SOLUTION |
0.54 g |
INTRAVENOUS |
NDA |
23 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-3200 |
SOLUTION |
2.17 g |
INTRAVENOUS |
ANDA |
20 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-3205 |
SOLUTION |
2.17 g |
INTRAVENOUS |
ANDA |
20 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-4500 |
SOLUTION |
2.17 g |
INTRAVENOUS |
ANDA |
20 sections
|
FreAmine III |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9010 |
INJECTION, SOLUTION |
0.71 g |
INTRAVENOUS |
NDA |
24 sections
|
FreAmine III |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9011 |
INJECTION, SOLUTION |
0.71 g |
INTRAVENOUS |
NDA |
24 sections
|
TrophAmine |
HUMAN PRESCRIPTION DRUG LABEL |
20 |
0264-9341 |
SOLUTION |
0.54 g |
INTRAVENOUS |
NDA |
23 sections
|
FreAmine HBC |
HUMAN PRESCRIPTION DRUG LABEL |
15 |
0264-9350 |
INJECTION, SOLUTION |
0.40 g |
INTRAVENOUS |
NDA |
24 sections
|
TrophAmine |
HUMAN PRESCRIPTION DRUG LABEL |
20 |
0264-9361 |
SOLUTION |
0.32 g |
INTRAVENOUS |
NDA |
23 sections
|
HepatAmine |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9371 |
INJECTION, SOLUTION |
0.77 g |
INTRAVENOUS |
NDA |
23 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-0180 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-0184 |
INJECTION, EMULSION |
1656 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-0188 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-0194 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-0198 |
INJECTION |
1242 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-0202 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-0206 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-0210 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-0214 |
INJECTION |
1656 mg |
INTRAVENOUS |
NDA |
20 sections
|
ProSol |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0338-0499 |
INJECTION, SOLUTION |
2.76 g |
INTRAVENOUS |
NDA |
21 sections
|
Clinisol |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0338-0502 |
INJECTION, SOLUTION |
2.17 g |
INTRAVENOUS |
ANDA |
18 sections
|
Travasol |
HUMAN PRESCRIPTION DRUG LABEL |
15 |
0338-0644 |
INJECTION |
2.07 g |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1089 |
INJECTION |
880 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1091 |
INJECTION |
880 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1099 |
INJECTION |
1035 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1101 |
INJECTION |
1035 mg |
INTRAVENOUS |
NDA |
21 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1113 |
INJECTION |
880 mg |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1115 |
INJECTION |
880 mg |
INTRAVENOUS |
NDA |
20 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1123 |
INJECTION |
1035 mg |
INTRAVENOUS |
NDA |
20 sections
|